Interim Guidelines for Pregnant Women During a Zika Virus Outbreak — United States, 2016
MMWR Early Release January 19, 2016 V.65 N.2 P.1-4
Emily E. Petersen, MD; J. Erin Staples, MD, PhD; Dana Meaney-Delman, MD, et al.
Corresponding author: Denise Jamieson, email@example.com, 770-488-6377.
1Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC; 2Arboviral Diseases Branch, National Center for Emerging and Zoonotic Infectious Diseases, CDC; 3Office of the Director, National Center for Emerging and Zoonotic Infectious Diseases, CDC.
Zika virus is a mosquito-borne flavivirus transmitted primarily by Aedes aegypti mosquitoes. The incidence of Zika virus infection in pregnant women is not currently known, and data on pregnant women infected with Zika virus are limited.
Zika virus infections have been confirmed in infants with microcephaly, and in the current outbreak in Brazil, a marked increase in the number of infants born with microcephaly has been reported.
Because there is neither a vaccine nor prophylactic medications available to prevent Zika virus infection, CDC recommends that all pregnant women consider postponing travel to areas where Zika virus transmission is ongoing.
Entry filed under: Biología Molecular, CONSENSOS, Epidemiología, FIEBRE en el POST-VIAJE, GUIDELINES, Infecciones emergentes, Infecciones en embarzadas, Infecciones virales, Medicina del viajero, Metodos diagnosticos, REPORTS, REVIEWS, Sepsis, Update.
Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia